Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Gianpaolo Marcacci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 62 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
- 31 Article
-
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
Gentile, M., Specchia, G., Derudas, D., Galli, M., Botta, C., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Attingenti, E., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G. & 36 others, , 2021, In: Haematologica.Research output: Contribution to journal › Article › peer-review
-
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
Gentile, M., Specchia, G., Derudas, D., Galli, M., Botta, C., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Attingenti, E., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G. & 36 others, , 2021, In: Haematologica. 106, 1, p. 291-294 4 p.Research output: Contribution to journal › Article › peer-review
-
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
Gentile, M., Specchia, G., Derudas, D., Galli, M., Botta, C., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Attingenti, E., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G. & 36 others, , Jan 1 2021, In: Haematologica. 106, 1, p. 291-294 4 p.Research output: Contribution to journal › Article › peer-review
-
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis
Laszlo, D., Marcacci, GP. P., Martino, M., Radice, D., Rabascio, C., Lucchetti, B., Magarò, A., Caime, A., Menna, S., Lionetti, MT. T. & Bertolini, F., 2020, In: Transfusion and Apheresis Science. 102819.Research output: Contribution to journal › Article › peer-review
-
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Girmenia, C., Bertaina, A., Piciocchi, A., Perruccio, K., Algarotti, A., Busca, A., Cattaneo, C., Raiola, A. M., Guidi, S., Iori, A. P., Candoni, A., Irrera, G., Castagna, L., Corradini, P., Alessandrino, E. P., Annaloro, C., Ciceri, F., Viscoli, C., Rossolini, G. M., Bertaina, A. & 31 others, , Dec 1 2017, In: Clinical Infectious Diseases. 65, 11, p. 1884-1896 13 p.Research output: Contribution to journal › Article › peer-review